Radiology Medical News about PET

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

[18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging
European Journal of Nuclear Medicine & Molecular Imaging, 10/02/09

Lemoine L et al. – [18F]F15599 is a radiofluorinated agonist presenting interesting characteristics for probing in vitro and in vivo the high–affinity states of the 5–HT1A receptors. Its differential labelling of 5–HT1A receptors in vitro and in vivo may result from its reported preferential interaction with receptors coupled to specific G–protein subtypes.

<< Previous
Double-Layered PTFE-Covered Nitinol Stents: Experience in 32...

Next >>
Clinical significance of 18F-fluoro-dexoxyglucose positron...

Positron emission tomography at the end of first-line therapy and during follow-up in patients with Hodgkin lymphoma: A retrospective study
Annals of Oncology, 11/11/09 Relevance Score: 96%

Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma
Journal of Clinical Endocrinology and Metabolism, 11/12/09 Relevance Score: 93%

Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer
European Journal of Radiology, 10/26/09 Relevance Score: 92%

Hodgkin's lymphoma in remission after first-line therapy: Which patients need FDG-PET/CT for follow-up?
Annals of Oncology, 11/17/09 Relevance Score: 91%

Miscellaneous Cancers (Lung, Thyroid, Renal Cancer, Myeloma, and Neuroendocrine Tumors): Role of SPECT and PET in Imaging Bone Metastases
Seminars in Nuclear Medicine, 10/14/09 Relevance Score: 90%